The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Direct Transcriptional Effects of Apolipoprotein E
Open accessAbstract
A major unanswered question in biology and medicine is the mechanism by which the product of the apolipoprotein E ε4 allele, the lipid-binding protein apolipoprotein E4 (ApoE4), plays a pivotal role in processes as disparate as Alzheimer's disease (AD; in which it is the single most important genetic risk factor), atherosclerotic cardiovascular disease, Lewy body dementia, hominid evolution, and inflammation. Using a combination of neural cell lines, skin fibroblasts from AD patients, and ApoE targeted replacement mouse brains, we show in the present report that ApoE4 undergoes nuclear translocation, binds double-stranded DNA with high affinity (low nanomolar), and functions as a transcription factor. Using chromatin immunoprecipitation and high-throughput DNA sequencing, our results indicate that the ApoE4 DNA binding sites include ∼1700 gene promoter regions. The genes associated with these promoters provide new insight into the mechanism by which AD risk is conferred by ApoE4, because they include genes associated with trophic support, programmed cell death, microtubule disassembly, synaptic function, aging, and insulin resistance, all processes that have been implicated in AD pathogenesis. SIGNIFICANCE STATEMENT This study shows for the first time that apolipoprotein E4 binds DNA with high affinity and that its binding sites include 1700 promoter regions that include genes associated with neurotrophins, programmed cell death, synaptic function, sirtuins and aging, and insulin resistance, all processes that have been implicated in Alzheimer's disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Apart from direct biochemical support to sustain myelin synthesis, it was demonstrated that APOE directly binds to promoter regions of SIRT1 to promote transcription in neurons (Theendakara et al. 2016).”
From Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport (2023) · cites this paper as Theendakara et al. 2016
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the referred alterations in gene expression associated to ApoE4 potentiate apoptotic and inflammatory pathways [37,43]”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ApoE4 also directly interacts with the promoter region of MAPK activating death domain (MADD), activity dependent neuroprotector homeobox (ADNP), COMM domain containing 6 (COMMD6) and protein phosphatase 2, regulatory subunit B’, epsilon isoform (PPP2R5E) genes, decreasing their expression.”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By affecting NRF1 transcriptional role, ApoE4 then influences the expression of its target genes, potentially involved in mitochondrial dynamics and Ca2+ handling [37].”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, it was shown that ApoE can translocate to nucleus, bind DNA, and function as a transcription factor in human glioblastoma cells [53].”
From Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease (2017) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“Genome-wide mapping of ApoE binding site indicated that ApoE4 binds the promoter regions of ∼1700 genes, including genes associated with synaptic function, neuroinflammation, and insulin resistance.”
From Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease (2017) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the classical role of APOE in cholesterol transport, APOE4 acquires a novel function in the nucleus, where it translocates and directly binds DNA to affect the transcription of genes associated with AD 45,46 .”
From APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints (2023) · cites this paper as [46]
The cited source says what the claim attributes to it.
In the citing paper
“recent studies postulate that ApoE4 may act as a transcription factor, regulating the expression of genes potentially involved in cellular and molecular pathways related to AD development [37].”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [37]
The cited source says what the claim attributes to it.
In the citing paper
“ApoE4 was reported to directly bind to the promoter region of SIRT1 gene, [37], decreasing its expression and enzymatic activity.”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of the endoplasmic reticulum protein-folding environment on cancer development
Wang, M., & Kaufman, R. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3800 · Cited by 1,152
Kauppinen, A., Suuronen, T., Ojala, J. O., Kaarniranta, K., & Salminen, A. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.007 · Cited by 1,016
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Origins of Specificity in Protein-DNA Recognition
Rohs, R., Jin, X., West, S. M., Joshi, R., Honig, B. H., & Mann, R. S. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060408-091030 · Cited by 902
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., Zhao, W., Thiyagarajan, M., MacGrogan, D., Rodgers, J. T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602909200 · Cited by 626
Apolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583 · cited 1×
“Although it is true that ApoE3 and ApoE4 are known to change structures depending on how much lipid is associated with the protein (Hatters et al., 2006; Peters-Libeu et al., 2006), it is likely that several different conformations of both ApoE3 and ApoE4 were present in our system.”
BackgroundSelf-citationSullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575
SIRT1 in Neurodevelopment and Brain Senescence
Herskovits, A. Z., & Guarente, L. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.028 · Cited by 504
Cited by
Sorted by citations
Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125
Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism
Mahley, R. W. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307023 · Cited by 516
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Safieh, M., Korczyn, A. D., & Michaelson, D. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1299-4 · Cited by 449
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Husain, M. A., Laurent, B., & Plourde, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.630502 · Cited by 353
Achariyar, T. M., Li, B., Peng, W., Verghese, P. B., Shi, Y., McConnell, E., Benraiss, A., Kasper, T., Song, W., Takano, T., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0138-8 · Cited by 256
Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210
APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints
Yin, Z., Rosenzweig, N., Kleemann, K. L., Zhang, X., Brandão, W., Margeta, M. A., Schroeder, C., Sivanathan, K. N., Silveira, S., Gauthier, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01627-6 · Cited by 202
“In addition to the classical role of APOE in cholesterol transport, APOE4 acquires a novel function in the nucleus, where it translocates and directly binds DNA to affect the transcription of genes associated with AD 45,46 .”
BackgroundHuebbe, P., & Rimbach, G. H. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.06.002 · Cited by 202
Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
Sepulcre, J., Grothe, M. J., Uquillas, F. D., Ortiz-Terán, L., Diez, I. P., Yang, H., Jacobs, H. I. L., Hanseeuw, B. J., Li, Q., Fakhri, G. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0206-4 · Cited by 195
Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease
Liao, F., Yoon, H., & Kim, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000383 · Cited by 191
Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
Bulck, M. V., Sierra‐Magro, A., Alarcón-Gil, J., Pérez‐Castillo, A., & Morales-Garcia, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030719 · Cited by 186
Peng, J., Pang, J., Huang, L., Enkhjargal, B., Zhang, T., Mo, J., Wu, P., Xu, W., Zuo, Y., Peng, J., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101121 · Cited by 160
Intracellular Cholesterol Trafficking and Impact in Neurodegeneration
Arenas, F., García‐Ruiz, C., & Fernández-Checa, J. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00382 · Cited by 171
Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157
APOE alleles and diet in brain aging and Alzheimer's disease
Yassine, H. N., & Finch, C. E. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00150 · Cited by 145
APOE genotype and stress response - a mini review
Dose, J., Huebbe, P., Nebel, A., & Rimbach, G. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0288-2 · Cited by 137
Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs
Parcon, P. A., Balasubramaniam, M., Ayyadevara, S., Jones, R. A., Liu, L., Shmookler Reis, R. J., Barger, S. W., Mrak, R. E., & Griffin, W. S. T. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.07.754 · Cited by 122
Insights into T‐cell dysfunction in Alzheimer's disease
Dai, L., & Shen, Y. (2021) · Aging Cell · doi:10.1111/acel.13511 · Cited by 123
Amyloid-β oligomers in cellular models of Alzheimer’s disease
Fontana, I. C., Zimmer, A. R., Rocha, A. S., Gosmann, G., Souza, D. O., Lourenco, M. V., Ferreira, S. T., & Zimmer, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15030 · Cited by 115
Destabilizing heterochromatin by APOE mediates senescence
Zhao, H., Ji, Q., Wu, Z., Wang, S., Ren, J., Yan, K., Wang, Z., Hu, J., Chu, Q., Hu, H., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00186-z · Cited by 104
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
Uchoa, M. F., Moser, V. A., & Pike, C. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.09.001 · Cited by 105
Rao, R. V., Subramaniam, K. G., Gregory, J., Bredesen, A. L., Coward, C., Okada, S., Kelly, L., & Bredesen, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021659 · Cited by 109
Self-citationThe interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
Jembrek, M. J., Slade, N., Hof, P. R., & Šimić, G. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.001 · Cited by 101
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.
Arbor, S., LaFontaine, M., & Cumbay, M. G. (2016) · Europe PMC (PubMed Central) · Cited by 94
Cacabelos, R., Carril, J. C., Cacabelos, N., Kazantsev, A. G., Vostrov, A. A., Corzo, L., Cacabelos, P., & Goldgaber, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051249 · Cited by 87
Carling, G. K., Fan, L., Foxe, N. R., Norman, K., Wong, M. Y., Zhu, D., Corona, C., Razzoli, A., Yu, F., Yarahmady, A., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.006 · Cited by 89
Gamache, J., Yun, Y., & Chiba-Falek, O. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045211 · Cited by 84
Famenini, S., Rigali, E. A., Perez, H. O., Dang, J., Chang, M. T., Halder, R. C., Rao, R. V., Pellegrini, M. A., Porter, V. R., Bredesen, D. E., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600677rr · Cited by 80
Self-citationIncreased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease
Zimetti, F., Caffarra, P., Ronda, N., Favari, E., Adorni, M. P., Zanotti, I., Bernini, F., Barocco, F., Spallazzi, M., Galimberti, D., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160411 · Cited by 75
Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics
Olivier, I. S., Cacabelos, R., & Naidoo, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113594 · Cited by 74
Mendonça, C. F., Kuras, M., Nogueira, F. C. S., Plá, I., Hortobágyi, T., Csiba, L., Palkovits, M., Renner, É., Döme, P., Marko‐Varga, G., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104509 · Cited by 69
Allard, J. S., Ntekim, O. E., Johnson, S. P., Ngwa, J. S., Bond, V., Pinder, D., Gillum, R. F., Fungwe, T. V., Kwagyan, J., & Obisesan, T. O. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.001 · Cited by 69
Elgenaidi, I. S., & Spiers, P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.011 · Cited by 67
Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
Theendakara, V., Peters-Libeu, C. A., Bredesen, D. E., & Rao, R. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0757-2 · Cited by 63
Self-citationIntroducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation
Hadar, A., Kapitansky, O., Ganaiem, M., Sragovich, S., Lobyntseva, A., Giladi, E., Yeheskel, A., Avitan, A. K., Vatine, G. D., Gurwitz, D., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01143-9 · Cited by 63
Rieker, C., Migliavacca, E., Vaucher, A., Mayer, F. C., Baud, G., Marquis, J., Charpagne, A., Hegde, N., Guignard, L., McLachlan, M. J., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312261 · Cited by 59
The Relationship Between Adverse Childhood Experiences and Alzheimer's Disease: A Systematic Review
Corney, K. B., West, E. C., Quirk, S. E., Pasco, J. A., Stuart, A. L., Manavi, B. A., Kavanagh, B. E., & Williams, L. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.831378 · Cited by 65
The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease
Zeitlow, K., Charlambous, L., Ng, I., Gagrani, S., Mihovilovic, M., Luo, S., Rock, D. L., Saunders, A. M., Roses, A. D., & Gottschalk, W. K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.031 · Cited by 56
Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease
Mamun, A. A., Uddin, M. S., Bashar, M. F. B., Zaman, S., Begum, Y., Bulbul, I. J., Islam, M. S., Sarwar, M. S., Mathew, B., Amran, M. S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5086250 · Cited by 54
Yang, X., Chen, S., Shao, Z., Li, Y., Wu, H., Li, X., Mao, L., Zhou, Z., Bai, L., Mei, X., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00142 · Cited by 52
Yang, A., Kantor, B., & Chiba‐Falek, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031244 · Cited by 51
Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro
Muth, C., Hartmann, A., Falla, D. S., Glatzel, M., & Krasemann, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00181 · Cited by 47
Apolipoprotein E and Atherosclerosis
Marais, A. D. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00933-4 · Cited by 53
Pontifex, M. G., Vauzour, D., & Minihane, A. M. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.017 · Cited by 51
Chen, Y., Jin, H., Chen, J., Li, J., Găman, M., & Zou, Z. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02600-y · Cited by 56
Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease
Theendakara, V. P., Bredesen, D. E., & Rao, R. V. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.07.002 · Cited by 45
Self-citationA multi‐hit hypothesis for an APOE4 ‐dependent pathophysiological state
Steele, O. G., Stuart, A. C., Minkley, L., Shaw, K., Bonnar, O., Anderle, S., Penn, A. C., Rusted, J., Serpell, L., Hall, C., et al. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15685 · Cited by 44
Griffin, E. F., Scopel, S. E., Stephen, C. A., Holzhauer, A. C., Vaji, M. A., Tuckey, R. A., Berkowitz, L. A., Caldwell, K. A., & Caldwell, G. A. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.037218 · Cited by 48
Norwitz, N. G., Soto-Mota, A., Norwitz, S. G., & Clarke, K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00184 · Cited by 42
The Role of Apolipoprotein E Isoforms in Alzheimer’s Disease
Roda, A. R., Montoliu‐Gaya, L., & Villegas, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180740 · Cited by 41
Campagna, J. J., Spilman, P. R., Jagodzinska, B. M., Bai, D., Hatami, A., Zhu, C., Bilousova, T. V., Jun, M., Elias, C. J., Pham, J. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35687-8 · Cited by 39
Self-citationAlbrecht, D. S., Sagare, A., Pachicano, M., Sweeney, M. D., Toga, A., Zlokovic, B., Chui, H., Joe, E., Schneider, L., Morris, J. C., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.01.010 · Cited by 37
“The APOE4 interactions observed in the current study could be due to enhanced levels of cytokines, as APOE4 expression induces greater release of inflammatory cytokines in transfected cells and in vivo in humans (Fan et al., 2017a; Gale et al., 2014; Theendakara et al., 2016).”
BackgroundMok, K. K., Yeung, S. H., Cheng, G. W., Ma, I. W., Lee, R. H., Herrup, K., & Tse, K. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15748 · Cited by 37
Lima, D., Hacke, A. C. M., Inaba, J., Pessôa, C. A., & Kerman, K. (2019) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2019.107447 · Cited by 37
The Interplay Between Apolipoprotein E4 and the Autophagic–Endocytic–Lysosomal Axis
Schmukler, E., Michaelson, D. M., & Pinkas-Kramarski, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0892-4 · Cited by 35
Apolipoprotein E in Cardiovascular Diseases: Novel Aspects of an Old-fashioned Enigma
Liehn, E. A., Ponomariov, V., Diaconu, R., Streață, I., Ioana, M. I., Crespo-Avilan, G. E., Hernández‐Reséndiz, S., & Cabrera-Fuentes, H. A. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.08.008 · Cited by 30
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
Ferguson, C. M., Echeverria, D., Hassler, M. R., Ly, S., & Khvorova, A. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.006 · Cited by 34
Mullane, K., & Williams, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.027 · Cited by 32
Hashimoto, M., Matsuzaki, K., Hossain, S., Ito, T., Wakatsuki, H., Tanabe, Y., Ohno, M., Kato, S., Yamashita, K., & Shido, O. (2021) · Foods · doi:10.3390/foods10051130 · Cited by 32
Fote, G. M., Geller, N. R., Efstathiou, N. E., Hendricks, N., Vavvas, D. G., Reidling, J. C., Thompson, L. M., & Steffan, J. S. (2022) · Journal of Cell Science · doi:10.1242/jcs.258687 · Cited by 36
Hurley, M. J., Deacon, R. M. J., Beyer, K., Ioannou, E., Ibáñez, A. M., Teeling, J. L., & Cogram, P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.001 · Cited by 32
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer
Petros, A. M., Korepanova, A., Jakob, C. G., Qiu, W., Panchal, S. C., Wang, J., Dietrich, J. D., Brewer, J. T., Pohlki, F., Kling, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00178 · Cited by 32
Kantor, B., O’Donovan, B., & Chiba‐Falek, O. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102635 · Cited by 38
Hadar, A., Milanesi, E., Squassina, A., Niola, P., Chillotti, C., Pasmanik-Chor, M., Yaron, O., Pavel Martasek, E., Rehavi, M., Weissglas‐Volkov, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.179 · Cited by 31
Inflammation in Alzheimer’s Disease: Do Sex and APOE Matter?
Duarte‐Guterman, P., Initiative, O. B. O. T. A. D. N., Albert, A., Inkster, A. M., Barha, C. K., & Galea, L. A. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200982 · Cited by 31
Gene regulation in adult neural stem cells. Current challenges and possible applications
Encinas, J. M., & Fitzsimons, C. P. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.016 · Cited by 32
Jung, J., Volk, C., Marga, C., Santos, A. N., Jung, M., Rujescu, D., & Santos, A. N. (2019) · Cellular Reprogramming · doi:10.1089/cell.2019.0010 · Cited by 29
Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function
Rueter, J., Rimbach, G. H., & Huebbe, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04516-7 · Cited by 32
Desimone, A. M. L., Hong, J., Brockie, S. T., Yu, W., Laliberté, A. M., & Fehlings, M. G. (2021) · JCI Insight · doi:10.1172/jci.insight.149227 · Cited by 29
An Adaptive Role for DNA Double-Strand Breaks in Hippocampus-Dependent Learning and Memory
Boutros, S. W., Unni, V. K., & Raber, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158352 · Cited by 31
Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging
Sil, S., Niu, F., Chivero, E. T., Singh, S., Periyasamy, P., & Buch, S. J. (2020) · Cells · doi:10.3390/cells9081857 · Cited by 28
Aging and Apolipoprotein E in HIV Infection
Geffin, R., & McCarthy, M. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0660-2 · Cited by 29
Pang, J., Wu, Y., Peng, J., Yang, P., Li, K., Qin, X., Cao, F., Sun, X., Chen, L., Vitek, M. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10821 · Cited by 25
Rao, R. V., Kumar, S., Gregory, J., Coward, C., Okada, S., Lipa, W., Kelly, L., & Bredesen, D. E. (2021) · Biomedicines · doi:10.3390/biomedicines9101348 · Cited by 24
Self-citationIslam, S., Sun, Y., Gao, Y., Nakamura, T., Noorani, A. A., Li, T., Wong, P. C., Kimura, N., Matsubara, E., Kasuga, K., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2039-21.2021 · Cited by 23
Hashimoto, M., Matsuzaki, K., Maruyama, K., Sumiyoshi, E., Hossain, S., Wakatsuki, H., Kato, S., Ohno, M., Tanabe, Y., Kuroda, Y., et al. (2022) · Food & Function · doi:10.1039/d2fo00723a · Cited by 24
Nuclear Localization of Apolipoprotein E4: A New Trick for an Old Protein
Rohn, T. T. (2017) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/1410067 · Cited by 23
Zhou, X., Fu, A. K. Y., & Ip, N. Y. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.02.001 · Cited by 23
Liu, A., Wang, T., Yang, L., & Zhou, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15070675 · Cited by 23
(2017) · PubMed Central · Cited by 20
Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before
Lee, L. C., Goh, M. Q. L., & Koo, E. H. (2017) · BioEssays · doi:10.1002/bies.201700062 · Cited by 20
Human apolipoprotein E glycosylation and sialylation: from structure to function
Moon, H.-J., Luo, Y., Chugh, D., & Zhao, L. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1399965 · Cited by 18
A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
Chen, H., Chen, F., Jiang, Y., Zhang, L., Hu, G., Sun, F., Zhang, M., Ji, Y., Chen, Y., Che, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881239 · Cited by 19
Liu, B., Fang, L., Mo, P., Chen, C., Ji, Y., Pang, L., Chen, H., Deng, Y., Ou, W., & Liu, S. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110696 · Cited by 19
APOE–NOTCH axis governs elastogenesis during human cardiac valve remodeling
Liu, Z., Liu, Y., Yu, Z., Tan, C., Pek, N. M. Q., O’Donnell, A., Wu, A., Glass, I. A., Winlaw, D. S., Guo, M., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00510-3 · Cited by 18
Laparra, I. C., Juárez‐Escoto, E., Vicario‐Abejón, C., Moratalla, R., & García‐Sanz, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1087072 · Cited by 17
Inoue, M., Suzuki, H., Meno, K., Liu, S., Korenaga, T., & Uchida, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713064 · Cited by 18
Mao, M., Chen, Y., Liu, R., Lü, H.-Q., Gu, J., Jiang, Z., & Jiang, J.-L. (2018) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2018.10.001 · Cited by 17
Analysis of high‐risk pedigrees identifies 11 candidate variants for Alzheimer's disease
Teerlink, C. C., Miller, J. B., Vance, E. L., Staley, L. A., Stevens, J., Tavana, J. P., Cloward, M. E., Page, M. L., Dayton, L., Cannon‐Albright, L., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12397 · Cited by 16
Onaolapo, O. J., Onaolapo, A. Y., Olowe, O. A., Udoh, M. O., Udoh, D. O., & Nathaniel, I. T. (2019) · Current Neuropharmacology · doi:10.2174/1570159x18666191230114339 · Cited by 16
Prasinou, P., Dafnis, I., Giacometti, G., Ferreri, C., Chroni, A., & Chatgilialoglu, C. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.07.001 · Cited by 15
A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer’s Disease
Chen, H., Chen, F., Zhang, M., Chen, Y., Cui, L., & Liang, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210602 · Cited by 15
Colas, J., Chessel, N., Ouared, A., Gruz-Gibelli, E., Marin, P., Herrmann, F. R., & Savioz, A. (2020) · Neural Plasticity · doi:10.1155/2020/9369815 · Cited by 14
Kurakin, A. V., & Bredesen, D. E. (2020) · Aging · doi:10.18632/aging.103883 · Cited by 15
Self-citationInsights into the roles of Apolipoprotein E in adipocyte biology and obesity
Jiang, C., & Lin, F. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01549-9 · Cited by 13
Ayurvedic Profiling of Alzheimer's Disease.
Bredesen, D. E., & Rao, R. V. (2017) · PubMed · Cited by 12
Self-citationLam, P. K., Wang, K., Chin, D. W. C., Tong, C. S. W., Wáng, Y. X. J., Lo, K. K. Y., Lai, P. B. S., Ma, H., Zheng, V. Z. Y., Poon, W. S., et al. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.08.051 · Cited by 11
Role of Autophagy in HIV-1 and Drug Abuse-Mediated Neuroinflammaging
Sil, S., Thangaraj, A., Oladapo, A., Hu, G., Kutchy, N. A., Liao, K., Buch, S. J., & Periyasamy, P. (2022) · Viruses · doi:10.3390/v15010044 · Cited by 10
Geffin, R., Martinez, R., Pozas, A. D. L., Issac, B., & McCarthy, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9734-9 · Cited by 10
Diaz, J. R., Martá-Ariza, M., Khodadadi‐Jamayran, A., Heguy, A., Tsirigos, A., Pankiewicz, J. E., Sullivan, P. M., & Sadowski, M. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.845291 · Cited by 11
Metadata
- Authors
- Theendakara, V., Peters-Libeu, C. A., Spilman, P., Poksay, K. S., Bredesen, D. E., & Rao, R. V.
- Affiliations
- Buck Institute for Research on Aging (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2016-01-20
- Volume
- 36
- Issue
- 3
- Pages
- 685-700
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4719010
- OpenAlex
- W2318325474
- Cited by
- 152
- References
- 55
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 14 · 2023: 13 · 2022: 13 · 2021: 22 · 2020: 11 · 2019: 21 · 2018: 16 · 2017: 17 · 2016: 12
- FWCI
- 17.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- Marin Community Foundation
- National Institutes of Health
- National Institute on Aging (AG034427, R01AG034427)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- APOE ε4, transcription factors, DNA binding, promoter binding sites, nuclear translocation, Alzheimer's disease risk, gene expression regulation, neurotrophins, programmed cell death, synaptic function, sirtuins, aging, insulin resistance, microtubule disassembly
- MeSH terms
- Aged, Animals, Base Sequence, Brain, Female, Fibroblasts, Humans, Male, Mice, Transgenic, Middle Aged, Molecular Sequence Data, Neurons, Protein Binding, Transcription, Genetic, Mice, Knockout, Cell Line, Tumor, Mice, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
